Qing Zhou

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 28

Top Venues

Thoracic cancer

Journal of translational medicine

Journal for immunotherapy of cancer

Oncoimmunology

This page only lists publications with an associated author ORCID identifier.

Publications

Shi-Qi Mei, Jia-Qi Liu, Zi-Jian Huang, Wei-Chi Luo, Ying-Long Peng, Zhi-Hong Chen, Yu Deng, Chong-Rui Xu, Qing Zhou
Identification of a risk score model based on tertiary lymphoid structure-related genes for predicting immunotherapy efficacy in non-small cell lung cancer. Thoracic cancer 15 (14) (2024)
Shi-Qi Mei, Jia-Qi Liu, Zi-Jian Huang, Wei-Chi Luo, Ying-Long Peng, Zhi-Hong Chen, Yu Deng, Chong-Rui Xu, Qing Zhou
Identification of a risk score model based on tertiary lymphoid structure-related genes for predicting immunotherapy efficacy in non-small cell lung cancer. Thoracic cancer 15 (14) (2024)
Wei-Chi Luo, Shi-Qi Mei, Zi-Jian Huang, Zhi-Hong Chen, Yi-Chen Zhang, Ming-Yi Yang, Jia-Qi Liu, Jing-Yan Xu, Xiao-Rong Yang, Ri-Wei Zhong, Li-Bo Tang, Lin-Xi Yin, Yu Deng, Ying-Long Peng, Chang Lu, Bao-Long Chen, Dong-Xian Ke, Hai-Yan Tu, Jin-Ji Yang, Chong-Rui Xu, Yi-Long Wu, Qing Zhou
Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancer. Journal of translational medicine 22 (1) (2024)
Shi-Qi Mei, Jia-Qi Liu, Zi-Jian Huang, Wei-Chi Luo, Ying-Long Peng, Zhi-Hong Chen, Yu Deng, Chong-Rui Xu, Qing Zhou
Identification of a risk score model based on tertiary lymphoid structure-related genes for predicting immunotherapy efficacy in non-small cell lung cancer. Thoracic cancer (2024)
Xue-Wu Wei, Chang Lu, Yi-Chen Zhang, Xue Fan, Chong-Rui Xu, Zhi-Hong Chen, Fen Wang, Xiao-Rong Yang, Jia-Yi Deng, Ming-Yi Yang, Qing Gou, Shi-Qi Mei, Wei-Chi Luo, Ri-Wei Zhong, Wen-Zhao Zhong, Jin-Ji Yang, Xu-Chao Zhang, Hai-Yan Tu, Yi-Long Wu, Qing Zhou
Redox high phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma. Oncoimmunology 13 (1) (2024)
Xue-Wu Wei, Chang Lu, Yi-Chen Zhang, Xue Fan, Chong-Rui Xu, Zhi-Hong Chen, Fen Wang, Xiao-Rong Yang, Jia-Yi Deng, Ming-Yi Yang, Qing Gou, Shi-Qi Mei, Wei-Chi Luo, Ri-Wei Zhong, Wen-Zhao Zhong, Jin-Ji Yang, Xu-Chao Zhang, Hai-Yan Tu, Yi-Long Wu, Qing Zhou
Redox high phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma. Oncoimmunology 13 (1) (2024)
Wei-Chi Luo, Shi-Qi Mei, Zi-Jian Huang, Zhi-Hong Chen, Yi-Chen Zhang, Ming-Yi Yang, Jia-Qi Liu, Jing-Yan Xu, Xiao-Rong Yang, Ri-Wei Zhong, Li-Bo Tang, Lin-Xi Yin, Yu Deng, Ying-Long Peng, Chang Lu, Bao-Long Chen, Dong-Xian Ke, Hai-Yan Tu, Jin-Ji Yang, Chong-Rui Xu, Yi-Long Wu, Qing Zhou
Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancer. Journal of translational medicine 22 (1) (2024)
Wei-Chi Luo, Shi-Qi Mei, Zi-Jian Huang, Zhi-Hong Chen, Yi-Chen Zhang, Ming-Yi Yang, Jia-Qi Liu, Jing-Yan Xu, Xiao-Rong Yang, Ri-Wei Zhong, Li-Bo Tang, Lin-Xi Yin, Yu Deng, Ying-Long Peng, Chang Lu, Bao-Long Chen, Dong-Xian Ke, Hai-Yan Tu, Jin-Ji Yang, Chong-Rui Xu, Yi-Long Wu, Qing Zhou
Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancer. Journal of translational medicine 22 (1) (2024)
Xue-Wu Wei, Chang Lu, Yi-Chen Zhang, Xue Fan, Chong-Rui Xu, Zhi-Hong Chen, Fen Wang, Xiao-Rong Yang, Jia-Yi Deng, Ming-Yi Yang, Qing Gou, Shi-Qi Mei, Wei-Chi Luo, Ri-Wei Zhong, Wen-Zhao Zhong, Jin-Ji Yang, Xu-Chao Zhang, Hai-Yan Tu, Yi-Long Wu, Qing Zhou
Redox high phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma. Oncoimmunology 13 (1) (2024)
Wei-Chi Luo, Shi-Qi Mei, Zi-Jian Huang, Zhi-Hong Chen, Yi-Chen Zhang, Ming-Yi Yang, Jia-Qi Liu, Jing-Yan Xu, Xiao-Rong Yang, Ri-Wei Zhong, Li-Bo Tang, Lin-Xi Yin, Yu Deng, Ying-Long Peng, Chang Lu, Bao-Long Chen, Dong-Xian Ke, Hai-Yan Tu, Jin-Ji Yang, Chong-Rui Xu, Yi-Long Wu, Qing Zhou
Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancer. Journal of translational medicine 22 (1) (2024)
Shi-Qi Mei, Jia-Qi Liu, Zi-Jian Huang, Wei-Chi Luo, Ying-Long Peng, Zhi-Hong Chen, Yu Deng, Chong-Rui Xu, Qing Zhou
Identification of a risk score model based on tertiary lymphoid structure-related genes for predicting immunotherapy efficacy in non-small cell lung cancer. Thoracic cancer 15 (14) (2024)
Si-Yang Maggie Liu, Hai-Yan Tu, Xue-Wu Wei, Hong-Hong Yan, Xiao-Rong Dong, Jiu-Wei Cui, Zhen Zhou, Chong-Rui Xu, Ming-Ying Zheng, Yang-Si Li, Zhen Wang, Xiao-Yan Bai, An-Na Li, Yue-Li Sun, Jie Huang, Jia-Xin Lin, E E Ke, Bing-Fei Xu, Chang Lu, Yingying Du, Yuan Chen, Rui Ma, Bu-Hai Wang, Shun-Dong Cang, Bin-Chao Wang, Hua-Jun Chen, Jin-Ji Yang, Yangqiu Li, Qing Zhou, Yi-Long Wu
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial. Nature medicine (2023)
Jun Zhao, Xinmin Yu, Dingzhi Huang, Zhiyong Ma, Bo Gao, Jiuwei Cui, Qian Chu, Qing Zhou, Meili Sun, Daphne Day, Jingxun Wu, Hongming Pan, Lifeng Wang, Mark Voskoboynik, Zhehai Wang, Yunpeng Liu, Hui Li, Juan Zhang, Yanyan Peng, Yi-Long Wu
SAFFRON-103: a phase 1b study of the safety and efficacy of sitravatinib combined with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer. Journal for immunotherapy of cancer 11 (2) (2023)
Jia-Yi Deng, Qing Gou, Lingling Yang, Zhi-Hong Chen, Ming-Yi Yang, Xiao-Rong Yang, Hong-Hong Yan, Xue-Wu Wei, Jia-Qi Liu, Jian Su, Wen-Zhao Zhong, Chong-Rui Xu, Yi-Long Wu, Qing Zhou
Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer. Journal for immunotherapy of cancer 11 (7) (2023)
Cunte Chen, Si-Yang Maggie Liu, Yuchen Han, Ming Han, Qiuxiang Ou, Hua Bao, Ling Xu, Yi-Kai Zhang, Wen-Zhao Zhong, Wen-Zhao Zhong, Qing Zhou, Xue-Ning Yang, Yang W Shao, Yi-Long Wu, Si-Yang Liu, Yangqiu Li
Poor prognosis of intra-tumoural TRBV6-6 variants in EGFR-mutant NSCLC: Results from the ADJUVANT-CTONG1104 trial. Clinical and translational medicine 12 (4) (2022)
Jiakang Li, Jingyan Xu, Mingyi Yang, Qing Zhou
Therapeutic revolution for inoperable stage III non-small cell lung cancer in the immune era. Cancer biology & medicine (2022)
Wen-Zhao Zhong, Song Dong, Li Yan Ji, Jia Ying Zhou, Zhi Hong Chen, Jian Su, Qing Ge Zhu, Meng Min Wang, E E Ke, Hao Sun, Xue Tao Li, Jin Ji Yang, Qing Zhou, Xu Chao Zhang, Xuan Gao, Xue Ning Yang, Xuefeng Xia, Xin Yi, Wen-Zhao Zhong, Yi Long Wu
Intratumoral genetic and immune microenvironmental heterogeneity in T4N0M0 (diameter ≥ 7 cm) non-small cell lung cancers. Thoracic cancer 13 (9) (2022)
Lei Yang, Yun-Ting He, Song Dong, Xue-Wu Wei, Zhi-Hong Chen, Bo Zhang, Wei-Dong Chen, Xiao-Rong Yang, Fen Wang, Xue-Meng Shang, Wen-Zhao Zhong, Yi-Long Wu, Qing Zhou
Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma. Journal for immunotherapy of cancer 10 (2) (2022)
Wen-Zhao Zhong, Si-Yang Liu, Wei Gao, Si-Yang Maggie Liu, Hong-Hong Yan, Liyan Ji, Yu Chen, Yuhua Gong, Hong-Lian Lu, Jun-Tao Lin, Kai Yin, Ben-Yuan Jiang, Qiang Nie, Ri-Qiang Liao, Song Dong, Yanfang Guan, Pingping Dai, Xu Chao Zhang, Jin-Ji Yang, Hai-Yan Tu, Xuefeng Xia, Xin Yi, Qing Zhou, Wen-Zhao Zhong, Xue-Ning Yang, Yi-Long Wu
Longitudinal Undetectable Molecular Residual Disease Defines Potentially Cured Population in Localized Non-Small Cell Lung Cancer. Cancer discovery 12 (7) (2022)
Kai-Cheng Peng, Jun-Wei Su, Zhi Xie, Han-Min Wang, Mei-Mei Fang, Wen-Feng Li, Yu-Qing Chen, Xu-Hui Guan, Jian Su, Hong-Hong Yan, Xu Chao Zhang, Hai-Yan Tu, Qing Zhou, Hua-Jun Chen, Yi-Long Wu, Jin-Ji Yang
Clinical outcomes of EGFR+/METamp+ vs. EGFR+/METamp- untreated patients with advanced non-small cell lung cancer. Thoracic cancer 13 (11) (2022)
Cunte Chen, Si-Yang Maggie Liu, Yuchen Han, Qiuxiang Ou, Hua Bao, Ling Xu, Yi-Kai Zhang, Wen-Zhao Zhong, Wen-Zhao Zhong, Qing Zhou, Xue-Ning Yang, Yang W Shao, Yi-Long Wu, Si-Yang Liu, Yangqiu Li
Identification of TCR rearrangements specific for genetic alterations in EGFR-mutated non-small cell lung cancer: results from the ADJUVANT-CTONG1104 trial. Cancer immunology, immunotherapy : CII (2022)
Hui-Bo Feng, Yu Chen, Zhi Xie, Jie Jiang, Yu-Min Zhong, Wei-Bang Guo, Wen-Qing Yan, Zhi-Yi Lv, Dan-Xia Lu, Hong-Ling Liang, Fang-Ping Xu, Jin-Ji Yang, Xue-Ning Yang, Qing Zhou, Dong-Kun Zhang, Zhou Zhang, Shao-Kun Chuai, Heng-Hui Zhang, Yi-Long Wu, Xu Chao Zhang
High SHP2 expression determines the efficacy of PD-1/PD-L1 inhibitors in advanced KRAS mutant non-small cell lung cancer. Thoracic cancer 12 (19) (2021)
Xiao-Xiao Peng, Ruoying Yu, Xue Wu, Shu-Yu Wu, Can Pi, Zhi-Hong Chen, Xu-Chao Zhang, Cun-Yi Gao, Yang W Shao, Li Liu, Yi-Long Wu, Qing Zhou
Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR / ALK wild-type advanced non-small cell lung cancer. Journal for immunotherapy of cancer 8 (1) (2021)
Qing Zhou, Lin Wu, Pei Hu, Tongtong An, Jianying Zhou, Li Zhang, Xiao-Qing Liu, Feng Luo, Xin Zheng, Ying Cheng, Nong Yang, Junling Li, Jifeng Feng, Baohui Han, Yong Song, Kai Wang, Li Zhang, Jian Fang, Hong Zhao, Yongqian Shu, Xiao-Yan Lin, Zhihong Chen, Bin Gan, Wan-Hong Xu, Wei Tang, Xiaoying Zhang, Jin-Ji Yang, Xiao Xu, Yi-Long Wu
A novel third generation EGFR tyrosine kinase inhibitor Abivertinib for EGFR T790M mutant Non-Small Cell Lung Cancer: a multicenter phase1/2 study. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Xue-Wu Wei, Xin Gao, Xu Chao Zhang, Jin-Ji Yang, Zhi-Hong Chen, Yi-Long Wu, Qing Zhou
Mutational landscape and characteristics of ERBB2 in non-small cell lung cancer. Thoracic cancer 11 (6) (2020)
Xiao-Xiao Peng, Li-Xu Yan, Chao Liu, Si-Yun Wang, Wen-Feng Li, Xing Gao, Xue-Wu Wei, Qing Zhou
Benign disease prone to be misdiagnosed as malignant pulmonary nodules: Minute meningothelioid nodules. Thoracic cancer 10 (5) (2019)
Can Pi, Chong-Rui Xu, Ming-Feng Zhang, Xiao-Xiao Peng, Xue-Wu Wei, Xing Gao, Hong-Hong Yan, Qing Zhou
EGFR mutations in early-stage and advanced-stage lung adenocarcinoma: Analysis based on large-scale data from China. Thoracic cancer 9 (7) (2018)
Jin Kang, Hua-Jun Chen, Xu-Chao Zhang, Jian Su, Qing Zhou, Hai-Yan Tu, Zhen Wang, Bin-Chao Wang, Wen-Zhao Zhong, Xue-Ning Yang, Zhi-Hong Chen, Yan Ding, Xue Wu, Mei Wang, Jian-Gang Fu, Zhenfan Yang, Xian Zhang, Yang W Shao, Yi-Long Wu, Jin-Ji Yang
Heterogeneous responses and resistant mechanisms to crizotinib in ALK-positive advanced non-small cell lung cancer. Thoracic cancer 9 (9) (2018)

Qing Zhou.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Qing Zhou